Cradlewise Inc Patent Portfolio Analysis

Startup IP Intelligence Scintillation Research  ·  2026-09-14

One Filing, Four Inventors, and a Crib That Watches Breathing

Cradlewise Inc. holds 1 patent family: 0 granted and 1 published and pending. Filing began in 2025, with the most recent published filing dated 2025-03-12. The families appear in 1 patent office: United States.Patent figures from Google Patents Public Data, reviewed 2026-09-14. Funding: $12M Series A, 3one4 Capital, CRV and Footwork, 2026-09-03.

Cradlewise Inc. closed a $12M Series A on the strength of a product that mixes furniture with contactless monitoring. The patent record behind it is exactly one family, filed in 2025, still pending. What does a single published application tell you about a company at this stage?

The raise$12MSeries A, 3one4 Capital and CRV
Patent families10 granted, 1 published and pending
Granted share0%First grants around 2028
Stage one

Twelve Million Arrives After the Filing

3one4 Capital, CRV and Footwork put $12M into Cradlewise Inc., a company founded in 2019 that sells a cradle which rocks in response to a baby and monitors that baby without touching it. Furniture and instrumentation in one object. The money is the visible event. The paper trail underneath it is smaller than the cheque suggests, and the dates matter more than the total.

The last public filing is dated 2025-03-12. That is roughly eighteen months before this round closed. Anything the company filed after that date is still inside the publication window and invisible to anyone reading the public record, including this one. So the picture here is a lower bound. What can be verified is one family, filed in the United States, published and pending.

Stage two

Nothing Granted, Everything Still Open

The split is as stark as a portfolio split gets. Zero granted. One published and pending. There is no ribbon of granted rights at all, only the wide band of the application still moving through examination. First grants are expected around 2028. Until then nothing here is enforceable, and the claim language that will eventually matter is still being negotiated with an examiner rather than fixed on a certificate.

This is the ordinary shape of a company that filed recently rather than a company that filed thinly over a long period. Cradlewise Inc. was founded in 2019 and its first public filing lands in 2025. Six years of building a product before a patent application surfaces publicly. That gap is the most interesting number on this page, and it sets up everything that follows.

Six years of product, then one application.

Stage three

Furniture Class Meets Medical Diagnostic Class

The claims sit in two places. A47D, which is where cribs, cradles and nursery furniture live. And A61B, diagnosis and surgery. That pairing is the whole product described in classification codes: a piece of baby furniture that also performs measurement on a human body. The published title is plain about it, detecting presence or absence of babies in cradles using monitoring systems.

The A61B half is the consequential one. Furniture classes are quiet. Medical diagnostic classes are not. By filing across both, Cradlewise Inc. put its single application into a technical neighbourhood where the sensing methods are examined against a very large body of prior art. It also means the claim scope, once settled, is what does the work. There is no second family to fall back on.

Stage four

Four Names, One Family, No Repeat

Four inventors are named on the application. Pawan Kumar Yadav appears on one of one, as do Bharath Patil and Gaurav Parashar. Nobody is a repeat inventor because there is nothing to repeat on. This is a snapshot of a single team moment rather than an inventive history, and it reads as a group effort on one problem rather than one technologist filing steadily across years.

Four names on a first filing usually means the work crossed disciplines. Sensing, mechanics, software. That is consistent with a product that has to rock a cradle and read a sleeping infant at the same time. What the record cannot yet show is whether this group keeps filing. A second family with overlapping names would say a great deal about how the company treats its own inventions.

Stage five

One Circle Beside Six Very Large Ones

The same CPC groups over the last five years drew Philips with 686 families, Samsung with 644, Biosense Webster Israel with 388, Zhejiang University with 372, Medtronic with 289 and Huawei with 282. Against that, one. The scale difference is not a judgement on quality. It is a statement about what kind of asset a single application can be in a densely worked area of contactless physiological sensing.

In crowded classes, count buys very little and scope buys everything. A narrow claim in A61B is a narrow claim. A well drafted one that covers the specific act of detecting an infant in a cradle is something a much larger filer would have had no particular reason to write. Norbert Health filed into A61B5 the same week, which is a reminder of how many directions this classification serves.

Count buys very little here. Scope buys everything.

Stage six

Where the Hiring Points, Filings Do Not

Now the open roles. One hundred of them. Thirty six in software and AI, thirty two in go to market, eighteen other, nine in ops and finance, five in hardware. The company is hiring software at seven times the rate it is hiring hardware. The single patent family describes a cradle and a monitoring system, which is hardware and sensing. The build and the filing point in different directions.

That is the story. Cradlewise Inc. protected the object and is now staffing to build the layer above it, the models and the interpretation that turn a sensed signal into something a parent acts on. The 2028 grant horizon means the current claims will arrive after that layer is already shipping. Whether the record catches up is a question the next publication window answers, not this one.

A diagram building through 6 stages: the funding event, drawn as a single pulse with the amount; the record splitting into a narrow granted ribbon and a wide pending one, so the skew is visible; the CPC areas as proportional bands, largest first; the inventors as dots, with the most frequently named highlighted; the big filers in the same CPC groups as large circles, with this company as a small one on the same scale; the closing question, set large in italic, with the earlier stages dimmed behind it. $12M Series A, 2026-09-03 3one4 Capital and CRV Cradlewise Inc., founded 2019, United States 1 patent family 0 granted 1 pending 0% of the record is issued Where the claims cluster A47D 2 families diagnosis and surgery 1 family A61B 4 inventors named across the portfolio Pawan Kumar Yadav is named on 1 of 1 Bharath Patil is named on 1 of 1 Gaurav Parashar is named on 1 of 1 Inventor names do not establish ownership Filers in the same CPC groups, last five years Philips 686 Samsung 644 Biosense Webste… 388 Zhejiang Univer… 372 Cradlewise Inc. 1 Shared classification indicates a common field, not a direct competitor One family covers the cradle. Thirty six hires build the software. Which one becomes the asset?

Is a single pending family enough to matter?

One application in a crowded class can be a real asset or a placeholder. No single indicator settles it. Read these three together, and note that each is weak on its own.

Where this sits

A single unexamined placeholder

One pending family in a class worked by Philips and Samsung, with nothing following it. The record says very little either way.

Where the Hiring Points, Filings Do Not

Does a second family publish in 2026, and does it claim the software layer rather than the cradle?

Do any of the four named inventors appear again, and does the composition of the team shift toward machine learning?

How far does the A61B claim scope survive examination, given the density of prior art from the largest filers in that class?

Does the company extend beyond the United States, and if so, to which jurisdictions and on what timeline?

Following those four would tell you whether the patent record is being built to match the product Cradlewise Inc. is actually staffing to ship.

Common questions

How many patents does Cradlewise Inc. have?

Cradlewise Inc. holds 1 patent family as reviewed in 2026-09: 0 granted and 1 published and pending.

How many of Cradlewise Inc.'s patents are granted?

None of the 1 family has granted yet. On typical pendency the first grants would be expected around 2028.

What technology do Cradlewise Inc.'s patents cover?

Cradlewise Inc.'s claims cluster in A47D and diagnosis and surgery (A61B). Recent filing titles include "detecting presence or absence of babies in cradles using monitoring systems".

Where has Cradlewise Inc. filed patents?

Cradlewise Inc.'s families appear in 1 patent office: United States.

Which companies file patents in the same areas as Cradlewise Inc.?

The same CPC groups drew Philips, Samsung, Biosense Webster Israel and Zhejiang University over the last five years. Shared classification indicates a common technology field rather than direct competition.

Who invented Cradlewise Inc.'s patents?

4 inventors are named across the portfolio. The most frequently named is Pawan Kumar Yadav. Inventor names do not establish ownership, which is determined by assignment records.

How much has Cradlewise Inc. raised?

Cradlewise Inc. raised $12M in a Series A announced 2026-09-03, with 3one4 Capital, CRV, Footwork and SOSV among its investors.

GET IN TOUCH NOW!

    OR SCHEDULE A MEETING

    Shopping Cart (0 items)

    Subscribe to our newsletter

    Sign up to receive latest news, updates, promotions, and special offers delivered directly to your inbox.
    No, thanks